EFRACEA

This brand name is authorized in Ireland, Netherlands, Poland, United Kingdom

Active ingredients

The drug EFRACEA contains one active pharmaceutical ingredient (API):

1 Doxycycline
UNII N12000U13O - DOXYCYCLINE

Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis.

Read about Doxycycline

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
EFRACEA Modified-release hard capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01AA02 Doxycycline J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 156563, 210278
Country: IE Health Products Regulatory Authority Identifier(s): 29226
Country: NL Z-Index G-Standaard, PRK Identifier(s): 91049
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100249682

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.